Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy
- PMID: 6142304
- PMCID: PMC2987704
- DOI: 10.1016/s0140-6736(84)90994-2
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy
Abstract
Post-transplant lymphomas or other lymphoproliferative lesions, which were usually associated with Epstein-Barr virus infections, developed in 8, 4, 3, and 2 recipients, respectively, of cadaveric kidney, liver, heart, and heart-lung homografts. Reduction or discontinuance of immunosuppression caused regression of the lesions, often without subsequent rejection of the grafts. Chemotherapy and irradiation were not valuable. The findings may influence policies about treating other kinds of post-transplantation neoplasms.
References
-
- Penn I. The price of immunotherapy. Curr Probl Surg. 1981;18:681–751. - PubMed
-
- Klein G, Purtilo D. Summary: symposium on Epstein-Barr virus induced lymphoproliferative diseases in immunodeficient patients. Cancer Res. 1981;41:4302–04. - PubMed
-
- Geis WP, Iwatsuki S, Molnar Z, Giacchino JL, Kerman RH, Ing TS, Hano TE. Pseudolymphoma in renal allograft recipients. Arch Surg. 1978;113:461–66. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
